Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on InteliCare.
RELATED STOCKHEAD STORIES
News
Top 10 at 10: This niobium explorer is today’s Crean of the crop
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX rides high as gold, silver, copper, and iron ore surge; Nuix jumps 25pc
News
Market Highlights: ASX to edge closer to record high with oil and nickel stocks in focus today
Health & Biotech
InteliCare anticipates positive impact from increased Budget spending on aged care
Health & Biotech
ASX Health Winners December: Health stocks beat market, look ‘undervalued’ going into 2024
Health & Biotech
Check Up: The reason people quit weight-loss drugs
Health & Biotech
Check Up: Introducing the Brain Atlas, the largest map of the human brain. And recent ASX biotech winners
News
Rise and Shine: Everything you need to know before the ASX opens
News
In Case You Missed It: A happy pharma debutante, plus positive news for a bunch of explorers
Health & Biotech
InteliCare inks multi-million dollar binding reseller agreement and aged care deployment
News
Top 10 at 11: There’s movement on the market, but not much news to explain why
Health & Biotech
ASX Health Winners: Biotechs up 10pc in November, and Janus Henderson’s prediction for 2024
Health & Biotech
Check Up: Imugene’s oncolytic virus VAXINIA granted FDA’s Fast Track, but how effective is this novel therapy?
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Smug ASX ends Tuesday higher, but not much better
News
